NCIt definition : A fixed dose artemisinin-based combination therapy (ACT) consisting of artesunate,
a semi-synthetic derivative of the sesquiterpine lactone, and pyronaridine, a benzonaphthyridine
derivative, with anti-malarial and potential antiviral activities. Upon oral administration
of artesunate/pyronaridine and hydrolysis of artesunate's active endoperoxide bridge
moiety by liberated heme in parasite-infected red blood cells (RBCs), reactive oxygen
species and carbon-centered radicals form, which damage and kill parasitic organisms.
Pyronaridine inhibits the formation of beta-hematin, which results in the accumulation
of toxic heme within the parasite. In addition, pyronaridine inhibits glutathione-dependent
degradation of hematin. This promotes hematin-induced lysis of RBCs, resulting in
parasite death. Artesunate/pyronaridine may also exhibit antiviral activity against
some viruses by modulating the type-1 interferon (IFN) pathway.;